ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,621, issued on Nov. 11, was assigned to Astellas Institute for Regenerative Medicine (Westborough, Mass.).
"Mesenchymal stromal cells and uses related thereto" was invented by Erin Anne Kimbrel (Sudbury, Mass.), Robert P. Lanza (Clinton, Mass.), Jianlin Chu (Bedford, Mass.) and Nicholas Arthur Kouris (Hudson, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having ...